Health TrialsbyHealthPanel

Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure

ConditionPulpitis - Irreversible
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorAltamash Institute of Dental Medicine

About this trial

The success of pulpotomy treatment is affected by the type of biologically active material used.The effects of MTA and biodentine are compared in mature permanent teeth with caries exposure.It is expected that pulpotomy using biodentine will have a high success rate in caries exposed mature teeth compared to mineral trioxide aggregate.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

mature permanent teeth

Disqualifiers

Teeth with restorations

Trial design

Design model

Parallel

Treatments tested in this trial

  • Pulp Therapy with Mineral trioxide aggregate (MTA)

    Procedure/Surgery

    MTA allowed to set for twenty four hours

  • Pulp Therapy with Biodentine

    Procedure/Surgery

    Biodentine is triturated before use

Treatment groups

136 Participants
are divided into 2 treatment groups
Group A: Group A Mineral trioxide aggregate pulpotomyActive comparator 1 intervention
Group B: Group B Biodentine pulpotomyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Number of participants treated with MTA

Time frame
6 months
2

Number of Participants treated with Biodentine

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Altamash Institute of Dental Medicine

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: